TEX35 and hepatocellular carcinoma: TSC24, a potent iron chelator, has been shown to effectively inhibit human HCC tumor growth in studies by disrupting iron homeostasis, depleting available iron, and inducing cell-cycle arrest and apoptosis, with minimal toxicity observed at therapeutic doses, highlighting its potential as a treatment for HCC [143].